| metastatic/advanced - colorectal cancer (mCRC) | |||
| metastatic/advanced - colorectal cancer (mCRC) | mCRC - 1st line (L1) | mCRC - 2nd line (L2) | |
| atezolizumab based treatment | |||
| atezolizumab alone | IMblaze-370 ... | ||
| atezolizumab plus bevacizumab | BACCI BACCI | ||
| atezolizumab plus cometinib | Modul Cohort 4 | IMblaze-370 ... | |
| atezolizumab plus FOLFOXIRI plus bevacizumab | AtezoTRIBE | ||
| atezolizumab plus SoC | Modul Cohort 2 | ||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
